BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Diabetes mellitus
,
Lymphocyte
,
Holistic medicine
,
Lipitor
,
rs2230926
,
ERBB2
,
Apoptosis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cd274 protein, human
(compound)
NextBio Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
CD8+ T cells from OT-1 mice after exposure to PD-L1
Renal cell carcinoma PDL1+ biopsies of nivolumab non-responders and partial and complete responders
Primary and metastatic melanomas - PD-L1 positive or negative
Macrophages differentiated from monocytes and treated with interleukin-4 and 6
Explore Curated Studies Results
Literature
Most Relevant Literature
Machine learning predicts cancer subtypes and progression from blood immune signatures.
Novel Complex of PD-L1 Aptamer and Albumin Enhances Antitumor Efficacy In Vivo.
PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis pat…
Combination therapy for pancreatic cancer: anti-PD-(L)1-based strategy.
Determination of the number of observers needed to evaluate a subjective test and its application in…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GU…
Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' …
Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung Cancer
SMMART Adaptive Clinical Treatment (ACT) Trial
Durvalumab (MEDI4736) and Radiosurgery (fSRT vs. PULSAR) for the Treatment of Non-Small Cell Lung Ca…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ